SPXIQ
Home
/
Stocks
/
Healthcare
/
BIIB
59
SPXIQ
BIIB
Biogen Inc.
Healthcare
· Drug Manufacturers - General
$190.25
+8.1% upside
Mean Target
$205.67
Consensus
2.3 - Buy
Analysts
30
Rank
#105
/ 499
Upside Rank
#288
Analyst Price Target Distribution
$143
Low
$206
Median
$206
Mean
$260
High
Current $190
Mean $206
Median $206
91 estimates
Consensus
2.3 - Buy
52-Wk Low
$110.04
52-Wk High
$202.41
50-Day Avg
$181.47
Recent Analyst Ratings
Firm
Rating
Target
Prior
Date
Barclays
Equal-Weight
$185
—
2026-02-20
Wedbush
Neutral
$187
$178
2026-02-10
JP Morgan
Neutral
$230
$220
2026-02-09
Canaccord Genuity
Buy
$230
$220
2026-02-09
BMO Capital
Market Perform
$196
$165
2026-02-09
Healthcare Peers
ABT
ABBV
A
ALGN
AMGN
BAX
BDX
TECH
BSX
BMY
CAH
CNC
COR
CRL
CI
COO
CVS
DHR
DVA
DXCM
EW
ELV
GEHC
GILD